Alivus Life Sciences Ltd.

The sales slipped to Rs. 5365.97 millions for the March 2024 quarter as against Rs. 6213.20 millions during the year-ago period.The Company to register a -33.08%  fall in the net profit for the quarter ended March 2024.The Operating Profit of the company witnessed a decrease to 1445.77 millions from 2092.66 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202403	202303	% Var	202403	202303	% Var	202403	202303	% Var
Sales	5365.97	6213.20	-13.64	22832.14	21612.20	5.64	22832.14	21612.20	5.64
Other Income	31.31	28.36	10.40	120.42	289.57	-58.41	120.42	289.57	-58.41
PBIDT	1445.77	2092.66	-30.91	6862.88	6712.50	2.24	6862.88	6712.50	2.24
Interest	3.64	1.19	205.88	15.46	5.47	182.63	15.46	5.47	182.63
PBDT	1442.13	2091.47	-31.05	6847.42	6707.03	2.09	6847.42	6707.03	2.09
Depreciation	145.34	115.17	26.20	534.52	420.94	26.98	534.52	420.94	26.98
PBT	1296.79	1976.30	-34.38	6312.90	6286.09	0.43	6312.90	6286.09	0.43
TAX	317.42	512.73	-38.09	1604.02	1616.48	-0.77	1604.02	1616.48	-0.77
Deferred Tax	6.88	39.62	-82.64	81.88	110.37	-25.81	81.88	110.37	-25.81
PAT	979.37	1463.57	-33.08	4708.88	4669.61	0.84	4708.88	4669.61	0.84
Equity	245.05	245.05	0.00	245.05	245.05	0.00	245.05	245.05	0.00
PBIDTM(%)	26.94	33.68	-20.00	30.06	31.06	-3.22	30.06	31.06	-3.22